Orgenesis Market Cap

Orgenesis has a market cap or net worth of $1.64 million as of December 5, 2025. Its market cap has decreased by -71.85% in one year.

Market Cap

1.64M

Enterprise Value

18.70M

Revenue

899.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.25

Market Cap Chart

Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 1.64M, an increase of 549.20%. That is a compound annual growth rate of 12.94%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	1.64M	-83.29%
Dec 31, 2024	9.83M	-38.42%
Dec 29, 2023	15.96M	-67.96%
Dec 30, 2022	49.81M	-28.75%
Dec 31, 2021	69.91M	-35.68%
Dec 31, 2020	108.70M	44.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	824.30M
Elite Pharmaceuticals	558.58M
Glass House Brands	531.36M
CytoDyn	403.93M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M

Market Cap Rankings